Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / COM
-
Number of holders
-
87
-
Total 13F shares, excl. options
-
15,618,592
-
Shares change
-
+570,954
-
Total reported value, excl. options
-
$1,787,858,029
-
Value change
-
+$78,290,656
-
Put/Call ratio
-
116%
-
Number of buys
-
49
-
Number of sells
-
33
-
Price
-
$114.47
Institutional Holders of CHINA BIOLOGIC PRODS HLDGS I - COM (CBPO) as of Q3 2019
As of 30 Sep 2019 CHINA BIOLOGIC PRODS HLDGS I - COM (CBPO) had 87 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 15,618,592 shares of stock of the company.
Largest 10 holders included Capital Research Global Investors, HILLHOUSE CAPITAL ADVISORS, LTD., York Capital Management Global Advisors, LLC, Temasek Holdings (Private) Ltd, VANGUARD GROUP INC, HSBC HOLDINGS PLC, BANK OF AMERICA CORP /DE/, BlackRock Inc., FIL Ltd, and NORGES BANK.
This table shows 87 institutional shareholders of the security as of 30 Sep 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.